Erratum to: Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity (Clinical Orthopaedics and Related Research®, (2017), 475, 6, (1702-1711), 10.1007/s11999-017-5258-0)

Krista A. Goulding, Adam Schwartz, Steven J. Hattrup, R Randall, Donald Lee, Damian M. Rispoli, Daniel M. Lerman, Christopher Beauchamp

Research output: Contribution to journalComment/debate

Abstract

A financial disclosure statement was improperly reported in the published study, “Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.” The study should have included the following statement: “The institution of one of the authors (DL) has received, during the study period, funding from NCATS/NI1H (UL1 TR000445) for the utilization of the REDCap (Research Electronic Data Capture) database.” We apologize for the error.

Original languageEnglish (US)
Number of pages1
JournalClinical Orthopaedics and Related Research
Volume475
Issue number6
DOIs
StatePublished - Jun 1 2017
Externally publishedYes

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Fingerprint Dive into the research topics of 'Erratum to: Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity (Clinical Orthopaedics and Related Research®, (2017), 475, 6, (1702-1711), 10.1007/s11999-017-5258-0)'. Together they form a unique fingerprint.

  • Cite this